Cognitive Behavior Therapy

Meredith L. C. Williamson, PhD
Kaylee Frutiger, PhD
Danielle L. Terry, PhD

American Family Physician. 2026;114(3):272-280.

Author Disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Cognitive behavior therapy is an evidence-based, time-limited psychotherapy that uses goal-oriented interventions to treat various mental and physical health conditions across the lifespan. It is used alone or with pharmacologic interventions to help patients modify problematic thoughts, behaviors, and emotions that maintain functional impairment. It is a primary treatment for tinnitus, fatigue, and trauma, somatic symptom, tic, insomnia, and borderline personality disorders. Cognitive behavior therapy or medication is the primary treatment for sexual dysfunction, anxiety, depressive, and obsessive-compulsive and related diagnoses. Cognitive behavior therapy can be a primary treatment or combined with medication-assisted treatment for substance-related and addictive disorders. It is an adjunctive treatment for attention-deficit/hyperactivity disorder, bipolar disorder, chronic pain conditions, irritable bowel syndrome, weight management, and menopause. Telehealth and digital interventions have demonstrated clinical benefits. Efficacy of cognitive behavior therapy ranges from small to large effect sizes compared with control conditions or treatment as usual. Integrated behavioral health teams may administer brief cognitive behavior interventions in the primary care setting.

Cognitive behavior therapy (CBT) is an evidence-based, time-limited psychological treatment with six decades of proven efficacy for numerous mental and physical health conditions.14 Core components involve interventions targeting modification or acceptance of problematic thoughts, memories, or beliefs that maintain functional impairment and distress (Figure 13); increased engagement in intentional behaviors that enhance functioning and reduce distress; increased beneficial emotional responses; and reduced avoidance of emotional responses. CBT may be implemented across the lifespan, with variability in treatment recommendations from childhood to adulthood. CBT is most effective when there is a collaborative and supportive patient-clinician relationship.5

WHAT'S NEW ON THIS TOPIC

Cognitive Behavior Therapy
Digital CBT delivered via synchronous telehealth modalities (eg, telephone, video conferencing) has been found as effective as in-person CBT delivered by licensed behavioral health clinicians for a range of mental and physical health concerns.
Studies of stand-alone CBT smartphone apps show minimal effects on mental health symptoms, but they may be a suitable first-step intervention for patients with limited access to care.

CBT = cognitive behavior therapy.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating Comments
CBT is recommended as primary treatment for tinnitus, fatigue, and insomnia, trauma, somatic symptom, tic, and borderline personality disorders.17,18,25,26,3439,4547,53,55,56,58,60,64,66,70 A Consistent evidence from randomized controlled trials, evidence-based practice guidelines, and systematic reviews
CBT is recommended as an adjunctive treatment for attention-deficit/hyperactivity disorder, bipolar disorder, chronic pain conditions, irritable bowel syndrome, weight management, and menopause.15,16,23,24,51,52,54,57,59,6163,65,68,69,71 B Systematic reviews and a limited number of randomized controlled trials
CBT or medication is the primary treatment for sexual dysfunction, anxiety, nonsevere depressive, and nonsevere obsessive-compulsive and related diagnoses.1214,19,20,2733 C Practice guidelines, randomized controlled trials, and systematic reviews
CBT combined with medication is recommended for severe, recurrent, or persistent depressive disorders, bulimia nervosa, binge-eating disorder, and severe obsessive-compulsive and related disorders.1922,27,28 C Practice guidelines, randomized controlled trials, and systematic reviews
CBT can be the primary treatment for substance use disorders or combined with medication-assisted treatment.4044 A Consistent evidence from randomized controlled trials, evidence-based practice guidelines, and systematic reviews

CBT = cognitive behavior therapy.

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

MEREDITH L. C. WILLIAMSON, PhD, ABPP, is a clinical associate professor and director of integrated behavioral health in the Department of Primary Care and Rural Medicine, and associate program director of the Texas A&M Family Medicine Residency Program at Texas A&M University Naresh K. Vashisht College of Medicine, Bryan.

KAYLEE FRUTIGER, PhD, is a clinical assistant professor in the Department of Primary Care and Rural Medicine and faculty at the Texas A&M Family Medicine Residency Program at Texas A&M University Naresh K. Vashisht College of Medicine, Bryan.

DANIELLE L. TERRY, PhD, ABPP, is director of behavioral health at the Guthrie Family Medicine Residency Program at Guthrie Medical Group, and an assistant professor of Psychiatry at the Neuroscience Institute at Geisinger Commonwealth School of Medicine, Sayre, Pennsylvania.

Address correspondence to Meredith L. C. Williamson, PhD, at meredith.williamson@tamu.edu.

Author Disclosure: No relevant financial relationships.

  1. 1.Beck JS. Cognitive Behavior Therapy: Basics and Beyond. 3rd ed. Guilford Press; 2020.
  2. 2.Butler AC, et al. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31.
  3. 3.Coffey SF, et al. Common questions about cognitive behavior therapy for psychiatric disorders. Am Fam Physician. 2015;92(9):807-812.
  4. 4.Hofmann SG, et al. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36(5):427-440.
  5. 5.Wampold BE. How important are the common factors in psychotherapy? An update. World Psychiatry. 2015;14(3):270-277.
  6. 6.Barlow DH, et al. The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2017;74(9):875-884.
  7. 7.Schaeuffele C, et al. A systematic review and meta-analysis of transdiagnostic cognitive behavioural therapies for emotional disorders. Nat Hum Behav. 2024;8(3):493-509.
  8. 8.Kazantzis N, et al. The processes of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2018;42(4):349-357.
  9. 9.McCracken LM, et al. New generation psychological treatments in chronic pain.. BMJ. 2022;376:e057212.
  10. 10.Wenzel A. Basic strategies of cognitive behavioral therapy. Psychiatr Clin North Am. 2017;40(4):597-609.
  11. 11.Gross JJ, Thompson RA. Emotion regulation. In: Gross JJ, ed. Handbook of Emotion Regulation. Guilford Press;2007:3–24.
  12. 12.Carpenter JK, et al. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502-514.
  13. 13.Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69(4):621-632.
  14. 14.Walter HJ, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2020;59(10):1107-1124.
  15. 15.Chiang KJ, et al. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials. PLoS One. 2017;12(5):e0176849.
  16. 16.Miklowitz DJ, et al. Adjunctive psycho therapy for bipolar disorder: a systematic review and component network meta-analysis. JAMA Psychiatry. 2021;78(2):141-150.
  17. 17.Crotty K, et al. Psychotherapies for the treatment of borderline personality disorder: a systematic review. J Consult Clin Psychol. 2024;92(5):275-295.
  18. 18.Stoffers-Winterling JM, et al. Psycho therapies for borderline personality disorder: a focused systematic review and meta-analysis. Br J Psychiatry. 2022;221(3):538-552.
  19. 19.US Department of Veterans Affairs; US Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder. 2022. Accessed December 10, 2025. https://www.healthquality.va.gov/healthquality/guidelines/mh/mdd/vadodmddcpg_providersummary_final_508_updated.pdf
  20. 20.Cheung AH, et al.; GLAD-PC Steering Group. Guidelines for adolescent depression in primary care (GLAD-PC): part II. Treatment and ongoing management. Pediatrics. 2018;141(3):e20174082.
  21. 21.Crone C, et al. The American Psychiatric Association practice guideline for the treatment of patients with eating disorders. Am J Psychiatry. 2023;180(2):167-171.
  22. 22.Linardon J, et al. The efficacy of cognitive-behavioral therapy for eating disorders: a systematic review and meta-analysis. J Consult Clin Psychol. 2017;85(11):1080-1094.
  23. 23.Nimmo-Smith V, et al. Non-pharmacological interventions for adult ADHD: a systematic review. Psychol Med. 2020;50(4):529-541.
  24. 24.Wolraich ML, et al.; Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528.
  25. 25.Pringsheim T, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896-906.
  26. 26.Shou S, et al. The efficacy of cognitive behavioral therapy for tic disorder: a meta-analysis and a literature review. Front Psychol. 2022;13:851250.
  27. 27.Loftus H, et al. A systematic review of nonpharmacological treatment options for skin picking disorder. Clin Exp Dermatol. 2025;50(2):299-306.
  28. 28.National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. November 29, 2005. Accessed December 19, 2025. https://www.nice.org.uk/guidance/cg31
  29. 29.Chronic pelvic pain: ACOG practice bulletin, number 218. Obstet Gynecol. 2020;135(3):e98-e109.
  30. 30.Boddi V, et al. An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study. Andrology. 2015;3(5):909-918.
  31. 31.Johnson S, et al. Biopsychosocial approaches for the management of female chronic pelvic pain: a systematic review. BJOG. 2025;132(3):266-277.
  32. 32.Liu M, et al. Cognitive behavior therapy for female sexual dysfunction: a systematic review and meta-analysis. Sex Med Rev. 2025;13(2):202-210.
  33. 33.Sharifipour F, et al. Impact of cognitive behavior therapy on sexual dysfunction of women in reproductive age: a systematic review. Int J Sex Health. 2024;36(3):287-301.
  34. 34.Morin CM. Cognitive behavioral therapy for chronic insomnia: state of the science versus current clinical practices. Ann Intern Med. 2015;163(3):236-237.
  35. 35.Schutte-Rodin S, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504.
  36. 36.Dewald-Kaufmann J, et al. Cognitive behavioral therapy for insomnia in school-aged children and adolescents. Sleep Med Clin. 2022;17(3):355-365.
  37. 37.Furukawa Y, et al. Components and delivery formats of cognitive behavioral therapy for chronic insomnia in adults: a systematic review and component network meta-analysis. JAMA Psychiatry. 2024;81(4):357-365.
  38. 38.LaFrance WC Jr, et al.; NES Treatment Trial (NEST-T) Consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014;71(9):997-1005.
  39. 39.Newby JM, et al. Internet-based cognitive behavioral therapy versus psychoeducation control for illness anxiety disorder and somatic symptom disorder: a randomized controlled trial. J Consult Clin Psychol. 2018;86(1):89-98.
  40. 40.Darker CD, et al. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Rev. 2015(5):CD009652.
  41. 41.Gregory VL Jr, Ellis RJB. Cognitive-behavioral therapy and buprenorphine for opioid use disorder: a systematic review and meta-analysis of randomized controlled trials. Am J Drug Alcohol Abuse. 2020;46(5):520-530.
  42. 42.Ray LA, et al. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6):e208279.
  43. 43.Rockhill CM, et al. Clinical practice guideline: assessment and treatment of adolescents and young adults with substance use disorders and problematic substance use (excluding tobacco). J Am Acad Child Adolesc Psychiatry. 2026;65(2):105-138.
  44. 44.VA/DoD Management of Substance Use Disorders Work Group. VA/DoD clinical practice guideline for the management of substance use disorders. 2021. Accessed December 10, 2025. https://www.healthquality.va.gov/healthquality/guidelines/mh/sud/va-dod-sudcpg_final_for-508_v3.pdf
  45. 45.Thielemann JFB, et al. A systematic review and meta-analysis of trauma-focused cognitive behavioral therapy for children and adolescents. Child Abuse Negl. 2022;134:105899.
  46. 46.VA/DoD Management of Posttraumatic Stress Disorder and Acute Stress Disorder Work Group. VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. 2023. Accessed June 24, 2026. https://healthquality.va.gov/healthquality/guidelines/mh/ptsd/va-dod-cpg-ptsd-full-cpg-edited-111624-v5-81825.pdf
  47. 47.Bisson JI, Olff M. Prevention and treatment of PTSD: the current evidence base. Eur J Psychotraumatol. 2021;12(1):1824381.
  48. 48.Guina J, et al. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21(4):281-303.
  49. 49.Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association Publishing; 2022.
  50. 50.Diefenbach GJ, et al. Brief cognitive behavioral therapy for suicidal inpatients: a randomized clinical trial. JAMA Psychiatry. 2024;81(12):1177-1186.
  51. 51.Bae JY, et al. Cognitive behavioral therapy for migraine headache:a systematic review and meta-analysis. Medicina (Kaunas). 2021;58(1):44.
  52. 52.Black CJ, et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69(8):1441-1451.
  53. 53.Blumenstein KG, et al. Effectiveness of cognitive behavioral therapy in improving functional health in cancer survivors: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2022;175:103709.
  54. 54.Fenlon D, et al. Effectiveness of nurse-led group CBT for hot flushes and night sweats in women with breast cancer: results of the MENOS4 randomised controlled trial. Psychooncology. 2020;29(10):1514-1523.
  55. 55.Fuller T, et al. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev. 2020(1):CD012614.
  56. 56.Grewal R, et al. Clinical efficacy of tinnitus retraining therapy and cognitive behavioural therapy in the treatment of subjective tinnitus: a systematic review. J Laryngol Otol. 2014;128(12):1028-1033.
  57. 57.Jacob A, et al. Impact of cognitive-behavioral interventions on weight loss and psychological outcomes: a meta-analysis. Health Psychol. 2018;37(5):417-432.
  58. 58.Maas Genannt Bermpohl F, et al. Efficacy and acceptance of cognitive behavioral therapy in adults with chronic fatigue syndrome: a meta-analysis. Int J Behav Med. 2024;31(6):895-910.
  59. 59.Moshiree B, et al. AGA clinical practice update on evaluation and management of belching, abdominal bloating, and distention: expert review. Gastroenterology. 2023;165(3):791.e3-800.e3.
  60. 60.Mustian KM, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961-968.
  61. 61.Thurston RC, et al. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
  62. 62.Skelly AC, et al. Noninvasive nonpharmacological treatment for chronic pain: a systematic review update. Comparative effectiveness review, no. 227. Agency for Healthcare Research and Quality; April 2020. Accessed June 24, 2026. https://www.ncbi.nlm.nih.gov/books/NBK556229
  63. 63.Sockalingam S, et al. Efficacy of telephone-based cognitive behavioral therapy for weight loss, disordered eating, and psychological distress after bariatric surgery: a randomized clinical trial. JAMA Netw Open. 2023;6(8):e2327099.
  64. 64.van den Akker LE, et al. Effectiveness of cognitive behavioral therapy for the treatment of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. J Psychosom Res. 2016;90:33-42.
  65. 65.Williams ACC, et al. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020(8):CD007407.
  66. 66.Zeraatkar D, et al. Interventions for the management of long covid (post-covid condition): living systematic review. BMJ. 2024;387:e081318.
  67. 67.Nakao M, et al. Cognitive-behavioral therapy for management of mental health and stress-related disorders: recent advances in techniques and technologies. Biopsychosoc Med. 2021;15(1):16.
  68. 68.Powers SW, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622-2630.
  69. 69.Niknejad B, et al. Association between psychological interventions and chronic pain outcomes in older adults: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(6):830-839.
  70. 70.Knoop H, et al. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial. Pediatrics. 2008;121(3):e619-e625.
  71. 71.Gordon M, et al. Psychosocial interventions for the treatment of functional abdominal pain disorders in children: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(6):560-568.
  72. 72.Brent D, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913.
  73. 73.Pilling S, et al.; Guideline Development Group. Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance. BMJ. 2013;346:f2541.
  74. 74.Gregory VL Jr, et al. Digital cognitive-behavioral therapy for substance use: systematic review and meta-analysis of randomized controlled trials. Am J Drug Alcohol Abuse. 2024;50(6):771-785.
  75. 75.Matsumoto K, et al. Effectiveness of videoconference-delivered cognitive behavioral therapy for adults with psychiatric disorders: systematic and meta-analytic review. J Med Internet Res. 2021;23(12):e31293.
  76. 76.Zandieh S, et al. Therapist-guided remote versus in-person cognitive behavioural therapy: a systematic review and meta-analysis of randomized controlled trials. CMAJ. 2024;196(10):e327-e340.
  77. 77.McCurry SM, et al. Effect of telephone cognitive behavioral therapy for insomnia in older adults with osteoarthritis pain: a randomized clinical trial. JAMA Intern Med. 2021;181(4):530-538.
  78. 78.Gilbody S, et al.; REEACT Team. Computerised cognitive behaviour therapy as treatment for depression in primary care: large scale pragmatic randomised controlled trial. BMJ. 2015;351:h5627.
  79. 79.Karyotaki E, et al.; Individual Patient Data Meta-Analyses for Depression Collaboration. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry. 2021;78(4):361-371.
  80. 80.Olthuis JV, et al. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016(3):CD011565.
  81. 81.Linardon J, et al. Current evidence on the efficacy of mental health smartphone apps for symptoms of depression and anxiety. A meta-analysis of 176 randomized controlled trials. World Psychiatry. 2024;23(1):139-149.
  82. 82.Chen LT, et al. Systematic review: the integration of artificial intelligence-powered cognitive-behavioural therapy for autonomous mental health management. Arch Psychiatr Nurs. 2025;57:151916.
  83. 83.Milne-Ives M, et al. Artificial intelligence and machine learning in mobile apps for mental health: a scoping review. PLOS Digit Health. 2022;1(8):e0000079.
  84. 84.Tay KW, et al. Cognitive behavioural therapy can be effective in treating anxiety and depression in persons with dementia: a systematic review. Psychogeriatrics. 2019;19(3):264-275.
  85. 85.Prior D, et al. Behavioural and cognitive-behavioural interventions for outwardly directed aggressive behaviour in people with intellectual disabilities. Cochrane Database Syst Rev. 2023(2):CD003406.
  86. 86.Carey M, et al. Are cognitive behavioural therapy, cognitive therapy, and behavioural activation for depression effective in primary care? A systematic review and meta-analysis. J Affect Disord. 2025;382:215-226.
  87. 87.Cully JA, et al. Delivery of brief cognitive behavioral therapy for medically ill patients in primary care: a pragmatic randomized clinical trial. J Gen Intern Med. 2017;32(9):1014-1024.
  88. 88.Cully JA, et al. Brief cognitive-behavioral therapy for depression in community clinics: a hybrid effectiveness-implementation trial. Psychiatr Serv. 2024;75(3):237-245.
  89. 89.Davidson JR, et al. Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomes. Br J Gen Pract. 2019;69(686):e657-e664.
  90. 90.Santoft F, et al. Cognitive behaviour therapy for depression in primary care: systematic review and meta-analysis. Psychol Med. 2019;49(8):1266-1274.
  91. 91.Anvari MS, et al. Behavioral activation disseminated by non–mental health professionals, paraprofessionals, and peers: a systematic review. Behav Ther. 2023;54(3):524-538.
  92. 92.Noetel M, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2024;384:e075847.
  93. 93.Patel C, Marmot M. Can general practitioners use training in relaxation and management of stress to reduce mild hypertension?. Br Med J (Clin Res Ed). 1988;296(6614):21-24.
  94. 94.McCormick E, et al. Training pediatric residents to provide parent education: a randomized controlled trial. Acad Pediatr. 2014;14(4):353-360.
  95. 95.Kwon M, et al. Brief behavioral treatment for insomnia: a meta-analysis. Behav Sleep Med. 2022;20(6):674-694.
  96. 96.Shahsavar Y, Choudhury A. Effectiveness of evidence based mental health apps on user health outcome: a systematic literature review. PLoS One. 2025;20(3):e0319983.
  97. 97.Doran GT. There's a S.M.A.R.T. way to write management's goals and objectives. Manage Rev. 1981;70(11):35-36.
  98. 98.Rupke SJ, et al. Cognitive therapy for depression. Am Fam Physician. 2006;73(1):83-86.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.